Corbus Pharmaceuticals Holding (CRBP) — Cash Flow-to-Debt Ratio
Corbus Pharmaceuticals Holding (CRBP) has a Cash Flow-to-Debt Ratio of -0.90x as of September 2025, meaning its operating cash flow of $-15.55 Million could theoretically repay -1% of its total liabilities ($17.37 Million) in one year. Check CRBP total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Corbus Pharmaceuticals Holding Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for Corbus Pharmaceuticals Holding across 13 annual periods. Also explore CRBP total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Corbus Pharmaceuticals Holding (2012–2024)
Year-by-year debt coverage analysis for Corbus Pharmaceuticals Holding. For market capitalisation and broader financial context, see market value of Corbus Pharmaceuticals Holding.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.11x | $-41.79 Million | $13.45 Million | ▼ -202.8% |
| 2023 | -1.03x | $-36.10 Million | $35.18 Million | ▲ +8.9% |
| 2022 | -1.13x | $-37.54 Million | $33.32 Million | ▲ +9.7% |
| 2021 | -1.25x | $-48.18 Million | $38.62 Million | ▲ +28.6% |
| 2020 | -1.75x | $-99.69 Million | $57.02 Million | ▼ -64.4% |
| 2019 | -1.06x | $-45.72 Million | $42.98 Million | ▲ +31.1% |
| 2018 | -1.54x | $-30.07 Million | $19.47 Million | ▲ +48.9% |
| 2017 | -3.02x | $-27.80 Million | $9.19 Million | ▼ -99.8% |
| 2016 | -1.51x | $-13.57 Million | $8.97 Million | ▼ -26.7% |
| 2015 | -1.19x | $-4.65 Million | $3.89 Million | ▲ +62.7% |
| 2014 | -3.20x | $-2.36 Million | $738.04K | ▼ -1722.3% |
| 2013 | -0.18x | $-366.71K | $2.09 Million | ▲ +83.0% |
| 2012 | -1.04x | $-769.73 | $743.36 | — |